Crown Nutraceuticals Receives FDA Approval for their RX Ultra Line Fertility Supplements in the United Arab Emirates.

San Diego, California – June 23, 2021 — Crown Nutraceuticals, an evidence-based fertility
supplement brand, announces marketing authorization approval by the United Arab Emirates
Ministry of Health and Prevention for their Ultra line of prescription fertility supplements.

The company is in the process of locating and securing a suitable distributor but holds market
authorization. UAE is a leader in IVF for the region, performing the most IVF cycles in all of the
MENA countries. The area receives the highest amount of IVF tourism from India, Pakistan,
Bangladesh, and all MENA countries.

“The approval of the Crown Fertility Ultra line in UAE completely changed the mindset of every
Urologist, OBGYN & IVF specialist in the MENA region,” said Fadi Atiya, Chief Executive Officer
of Crown Fertility. “Our scientifically-based natural products are the answer the East has been
looking for since the first cycle started.”

This approval comes after an over three-year process to obtain UAE FDA approval. The
approval will dramatically increase their business’s visibility. They are looking forward to a fruitful
future with their unique fertility offerings.

About Ultra Line

The Ultra Line is a prescription-only fertility supplement line formulated with evidence-based
ingredients to support healthy conception and successful pregnancy. Their Pro His RX and Pr
Hers RX formulas have now received marketing authorization approval by the United Arab
Emirates Ministry of Health and Prevention. The Ultra Line is specifically developed to help
families conceive naturally using essential and potent fertility-boosting ingredients.

About Crown Nutraceuticals

Crown Nutraceuticals is located in California. Their mission is to put control back in the hands of
individuals by providing essential supplements that serve in building families. The company’s
products are grounded in science, inspired by nature, and formulated using evidence-based
ingredients.

For additional information, please visit https://crownfertility.com.

Media Contact:
Henry (Hank) Douglas
Henry@crownfertility.com